Archive for September 2009

Not Enough Evidence To Support Routine Prostate Cancer Screening

There is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test, conclude two papers published on bmj.com today. The authors say that the PSA test cannot distinguish between lethal and harmless prostate cancer, leading to overdiagnosis and overtreatment of healthy men.

What Is Jaundice? What Causes Jaundice? What Is Icterus?

Jaundice, also known as icterus, is a term used to describe a yellowish tinge to the skin and sclerae (the white part of the eye) that is caused by hyperbilirubinemia (an excess of bilirubin in the blood). Body fluids may also be yellow.

MPharm Marking Allegations At The University Of Manchester

In July 2009, the Royal Pharmaceutical Society of Great Britain (RPSGB) became aware of alleged marking irregularities on the University of Manchester’s accredited Master of Pharmacy (MPharm) undergraduate degree. As the statutory regulator for pharmacy in Great Britain, the RPSGB is responsible for the accreditation of MPharm degrees.

Promising Results In Reducing Neuropathic Pain With Combined Drug Treatment, Than With Either Drug Alone

An article published Online First and in a future edition of The Lancet reports that combination treatment using gabapentin and nortriptyline reduces neuropathic pain more than either drug alone. This treatment could be used in patients that only partly respond to one drug or the other.

DispersinB(R) Topical Wound Gel Passes First Set Of Biocompatibility Tests

Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that DispersinBĀ® Topical Wound Gel has passed the FDA-recommended Cytotoxicity and Primary Skin Irritation tests conducted by WuXi AppTec Inc. (St. Paul, MN) in compliance with Good Laboratory Practice (GLP).

Religion Impacts Decision On Prostate Cancer Screening In African-American Men

African-American men are more likely to have had a digital rectal exam in the past year to screen for prostate cancer if they engage in religious behaviors, according to a University of Alabama at Birmingham (UAB) study published in the American Journal of Men’s Health. Study co-author Theresa A. Wynn, Ph.D.

Lessons From 1918 On Influenza-related School Closure Planning

During last spring’s influenza A/H1N1 pandemic, closing schools was a common and often contested strategy for curbing spread of the virus. This debate likely will persist if the flu pandemic continues or worsens in the United States this fall. Researchers from the University of Michigan and the Centers for Disease Control and Prevention conducted a qualitative analysis of 43 U.S.

Don’t Make Older People Wait For Treatment Say Doctors, Northern Ireland

At the start of Age Awareness Week in Northern Ireland for 2009, Dr Brian Patterson, Chairman of the British Medical Association’s Northern Ireland Council said, “As doctors, we treat people throughout the course of their lives, and strive to give the best care possible to older people in our society.

How Living Conditions Impact Reproductive Health

When costs outweigh benefits, successful pregnancies are less likely to occur. Life is all about tradeoffs and recently published research by Virginia J.

Although Most Surveyed Oncologists Prescribe It For Many Cancer Types, Avastin’s High Cost Remains A Barrier To Treatment For Some Patients

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that Roche/Chugai’s Avastin is prescribed by the majority of surveyed oncologists for glioblastoma multiforme, non-small-cell lung cancer and breast cancer. Additionally, the drug is prescribed by all surveyed oncologists for colorectal cancer.